On this page
Short answer Pregnancy and daratumumab: what to know Common questions Related questions Sources**No, daratumumab injection is not recommended during pregnancy unless your cancer team decides the benefit to you clearly outweighs the risk to the baby.**
Daratumumab is an antibody that crosses the placenta, and antibodies of this type can reduce a baby's immune cells before birth. Because of that, pregnancy is confirmed as negative before treatment starts, and effective birth control is advised during treatment and for 3 months after the last dose. The picture also depends on what daratumumab is combined with, since lenalidomide, thalidomide, and pomalidomide cause serious birth defects and carry their own pregnancy prevention requirements. If you are pregnant, think you may be, or want to conceive later, that is a conversation for your oncologist and an obstetrician together, not a decision to make by skipping infusions. Keep a written list of every drug in your regimen so any clinician you see knows exactly what you are on.
Pregnancy and daratumumab: what to know
Common questions
Can you take Daratumumab Injection while pregnant?
Daratumumab is an antibody that crosses the placenta and can lower a baby's immune cells, so it is not recommended in pregnancy. Your team will confirm you are not pregnant before you start and ask you to use effective birth control during treatment and for 3 months after the last dose. It is often given with lenalidomide, thalidomide, or pomalidomide, which cause serious birth defects and have strict pregnancy prevention programs. If you are pregnant or planning a pregnancy, tell your oncologist right away instead of stopping doses on your own. Babies exposed before birth may need live vaccines delayed until blood counts are checked.
